Whole Person Healing.
For All.
Pioneering a New Era
in Modern Medicine
Expertise Informed by Experience
Sunstone is guided by a team of Clinical Research Coordinators with over 30 years of combined clinical expertise and over 5 years of specialized experience in psychedelic research.
We are currently offering trials to address depression, treatment-resistant depression, postpartum depression, cancer and depression, adjustment disorder, and PTSD. These trials use a variety of psychedelic compounds including, but not limited to psilocybin, MDMA, and 5-MeO-DMT.
Explore Open Studies- Adjustment Disorder (AD)
- Advanced Illness
- Generalized Anxiety Disorder
- Major Depressive Disorder (MDD)
- MDD and Cancer
- Post-Traumatic Stress Disorder
- Postpartum Depression
- Treatment-Resistant Depression
- Psilocybin
- MDMA
- LSD
- 5-MeO-DMT
- Methylone
- RE-104 (novel serotonergic antidepressant)
- atai Life Sciences
- Beckley Psytech
- Compass Pathways
- Cybin
- Lykos Therapeutics
- MindMed
- Reunion Neuroscience
- Transcend Therapeutics
- Usona Institute
- Adventist HealthCare
- Dana-Farber Cancer Institute
- Johns Hopkins Center for Psychedelic &
Consciousness Research - McGill University
- Memorial Sloan Kettering Cancer Center
- The University of Vermont
Participating in a clinical trial at Sunstone contributes to advancing scientific knowledge in the field of mental health research. Sunstone’s clinical team has authored 11 papers on psychedelic research in leading journals, including Cancer, JAMA Oncology, and NIH-Heals.
View Published Research
Our Mission
Sunstone in the News
Manish Agrawal, MD joins Living Medicine host, Dr. Sandra Newes to discuss the challenges and future of psychedelic-assisted therapy research.
Manish Agrawal, MD joins Power to the Patient host Brandon Li to discuss the transformative role of psychedelics in cancer care and mental health.
Psychedelic-assisted therapies may be a promising treatment for combat related moral injury.
October 22, 2024 Sunstone Therapies is pleased to announce that Dr. Manish Agrawal was appointed by Maryland Governor Wes Moore […]
Psychedelic-assisted therapies bring a critical new dimension to questions about subjectivity in psychiatry.
Psychedelic-assisted therapies bring a critical new dimension to questions about subjectivity in psychiatry.
Dear Sunstone Community, It has been a pivotal couple of weeks for the field of psychedelic-assisted therapy (PAT) following the […]
Psychedelic-assisted therapies bring a critical new dimension to questions about subjectivity in psychiatry.
Dr. Manish Agrawal speaks PATs ability to treat not just the physical manifestations of cancer but also the mental and emotional toll it takes on patients.
Enhanced therapist training standards are necessary, along with an additional PAT therapists.